Skip to main content

Nikej Shah

NIH Rank #447
  • Program Leader
  • Top 5% Funded
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 15522339Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2026

Linked Award Amount
$4.9M
Full award amounts, FY2026
Award Records
1
Records listing this PI
Award-Linked Rank
#447
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Nikej Shah. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Nikej Shah as a PI. Multi-PI records show the full award amount for context.

  • 5U01DA061643-03U01
    Select Late-Stage CMC, Non-clinical Studies, and Quality Programs to Accelerate NRS-033 Towards Pivotal Studies and Registration in Opioid Use Disorder
    $4.9M
    award amount

Award organization

Organizations that administered FY2026 awards listing Nikej Shah as a PI.

FY2026 award administered by Nirsum Laboratories, Inc. (NY).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Nirsum Laboratories, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    Entered Top 50% Nationally
    Ranked #525
  7. 2024
    Entered Top 25% Nationally
    Ranked #525
  8. 2024
    Entered Top 10% Nationally
    Ranked #525
  9. 2024
    Entered Top 5% Nationally
    Ranked #525
  10. 2025
    $10M Cumulative Funding
  11. 2025
    Program/Center Grant Leader

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Nikej Shah.